Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: A rodent model of IL-4-induced hepatitis

Journal of Immunology

Volumn 166, Issue 8, 2001, Pages 5225-5235

  Guillot, C ^a   Coathalem, H ^a   Chetritt, J ^a   David, A ^a   Lowenstein, P ^a   Gilbert, E ^a   Tesson, L ^a   Van Rooijen, N ^a   Cuturi, M C ^a   Soulillou, J P ^a   Anegon, I ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CLODRONIC ACID; CYCLOPHOSPHAMIDE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE TRANSFER; HEPATITIS; LETHALITY; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035871842     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.8.5225     Document Type: Article

References (51)

1. Recombinant human interleukin-4 (IL-4) given as daily subcutaneous injections: A phase 1 dose toxicity trial
2. Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer: A phase 1 toxicity study and pharmacokinetic analysis
3. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma
4. Safety evaluation of recombinant human interleukin-4. I. Preclinical studies
5. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology
6. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis
7. Expression of high affinity receptors for murine interleukin 4 (BSF- I) on hemopoietic and nonhemopoietic cells
8. An update of interleukin.4 and its receptor
9. Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture
10. Interleukin 4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin 1, and interleukin 6 but not by interferon-α
11. + T cell for concanavalin A-induced hepatic injury in mice
12. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40
13. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes
14. Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors
15. IL-4-induced apoptosis in peripheral blood eosinophils
16. Adenovirus-mediated gene transfer in rat liver of IL-4 but not IL-10 produces severe acute hepatitis
17. Anti-adenovirus immune responses in rats are enhanced by interleukin-4 but not interleukin-10 produced by recombinant adenovirus
18. Widespread long-term gene transfer to mouse skeletal muscles and heart
19. Transient suppression of macrophage functions by liposome-encapsulated drugs
20. ICE family proteases: Mediators of all apoptotic cell death?
21. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis
22. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death
23. LPS challenge in D-galactosaminesensitized mice accounts for caspase- dependent fulminant hepatitis, not for septic shock
24. FAS-ligand, TNF-α expression and apoptosis during allograft rejection and tolerance
25. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and non-parenchymal rat liver cells
26. Apoptosis in liver disease
27. Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha; mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes
28. Protective effect of hepatocyte growth factor on interferon γ-induced cytotoxicity in mouse hepatocytes
29. The expression of 1L-2, IL-4 and interferon-γ, (IFN-γ) mRNA using liver biopsies at different phases of acute exacerbation of chronic hepatitis B
30. + surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with hepatitis B virus
31. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver
32. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig
33. Molecular characterization and functional analysis of murine interleukin 4 receptor allotypes
34. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice
35. Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells
36. Inhibition of angiogenesis by interleukin 4
37. 50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma
38. The IL-4 receptor: Signaling mechanisms and biologic functions
39. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common γ chain
40. Hepatic failure and liver damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis
41. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
42. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death
43. From bench to clinic with apoptosis-based therapeutic agents
44. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production
45. Pathophysiological roles of interleukin-18 in inflammatory liver diseases
46. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
47. Disparate roles for TNF-α and FasL in concanavalin-A-induced hepatitis
48. Triggering and modulation of apoptosis by oxidative stress
49. Caspase inhibition reduces apoptosis and increases survival of nigral transplants
50. IL-4 induces apoptosis of endothelial cells through the caspase-3-dependent pathway